Education
About Us
Working with TipRanks
Follow Us
Anbio Biotechnology Class A (NNNN)
NASDAQ:NNNN
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 8.19M | $ 6.71M | $ 23.54M | $ 4.43M |
| Gross Profit | $ 5.89M | $ 3.36M | $ 12.56M | $ 2.54M |
| Operating Income | $ 2.00M | $ 1.96M | $ 10.20M | $ 2.46M |
| EBITDA | $ 2.57M | $ 2.45M | $ 10.03M | $ 2.54M |
| Net Income | $ 2.37M | $ 2.25M | $ 10.01M | $ 2.54M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 11.76M | $ 9.69M | $ 8.67M | $ 4.18M |
| Total Assets | $ 18.92M | $ 15.81M | $ 13.96M | $ 4.92M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -11.76M | $ -9.69M | $ -7.10M | $ -4.18M |
| Total Liabilities | $ 1.73M | $ 993.06K | $ 1.41M | $ 2.38M |
| Stockholders' Equity | $ 17.19M | $ 14.82M | $ 12.55M | $ 2.54M |
| Cash Flow | ||||
| Free Cash Flow | $ 2.08M | $ 898.37K | $ 4.45M | $ 4.18M |
| Operating Cash Flow | $ 2.08M | $ 898.37K | $ 4.45M | $ 4.18M |
| Investing Cash Flow | $ 337.10K | $ 1.73M | $ -1.53M | $ 0.00 |
| Financing Cash Flow | $ -344.61K | $ -42.84K | $ 0.00 | $ 0.00 |
Anbio Biotechnology Class A Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.